Viewing Study NCT06686394

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 1:37 AM

Ignite Modification Date: 2025-12-26 @ 12:52 AM

Study NCT ID: NCT06686394

Status: RECRUITING

Last Update Posted: 2025-12-24

First Post: 2024-11-11

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

Sponsor: Merck Sharp & Dohme LLC

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module